Eleven Biotherapeutics completes debt financing

Eleven Biotherapeutics Inc. (NASDAQ:EBIO), Cambridge, Mass. Business: Ophthalmic Date completed: 2014-11-26 Type: Debt financing Raised: $10 million Investor: Silicon Valley Bank Note: Eleven drew dow...